19-122
Showing 1 - 25 of >10,000
COVID-19 Trial in United States (Camostat Mesilate, Placebo)
Completed
- COVID-19
- Camostat Mesilate
- Placebo
-
Palm Springs, California
- +20 more
Jan 13, 2022
COVID-19 Trial in Taichung (UB-612)
Completed
- COVID-19
- UB-612
-
Taichung, TaiwanChina Medical University Hospital
Feb 11, 2022
Primary Open-angle Glaucoma Trial in Bogotá, Zapopan (PRO-122, Timolol eye drops, Dorzolamide-Timolol Ophthalmic)
Recruiting
- Primary Open-angle Glaucoma
- PRO-122
- +6 more
-
Bogotá, Bogotá D.C., Colombia
- +1 more
Dec 22, 2021
COVID-19 Prevention Trial in Worldwide (Ad26.COV2.S)
Recruiting
- COVID-19 Prevention
- Ad26.COV2.S
-
Little Rock, Arkansas
- +54 more
Aug 2, 2022
Mental Health Wellness 1 Trial in Cali (The program comprises 12 sessions and additional activities to be carried out after each
Completed
- Mental Health Wellness 1
- The program comprises 12 sessions and additional activities to be carried out after each session, alongside counseling from the program's leading professionals
-
Cali, Valle Del Cauca, ColombiaArcadio de Jesús Cardona Isaza
Nov 9, 2023
ARDS, Hypercapnic Respiratory Failure, AKI Trial in Giessen (ECCO2R)
Recruiting
- ARDS
- +2 more
- ECCO2R
-
Giessen, Hessen, GermanyUniversity Hospital Giessen and Marburg, Giessen
Jan 23, 2023
HIV, Organ Transplantation, Lymphoma, Non-Hodgkin Trial in Melbourne (Pfizer Bivalent COVID-19 Vaccine, Moderna Bivalent mRNA
Recruiting
- HIV
- +5 more
- Pfizer Bivalent COVID-19 Vaccine
- Moderna Bivalent mRNA vaccine
-
Melbourne, Victoria, AustraliaAlfred Health
Jan 31, 2023
Covid-19, Coronavirus Disease 2019 Trial in Hialeah, Winter Park, Mesquite (Bempegaldesleukin, Standard of Care, Placebo)
Completed
- Covid-19
- Coronavirus Disease 2019
- Bempegaldesleukin
- +2 more
-
Hialeah, Florida
- +3 more
Mar 31, 2022
Acne Vulgaris Trial in Dhaka (Zinc sulphate tablet 20 mg, Placebo tablet 20 mg)
Completed
- Acne Vulgaris
- Zinc sulphate tablet 20 mg
- Placebo tablet 20 mg
-
Dhaka, BangladeshBasic Science and Paraclinical Science of BSMMU
Mar 6, 2022
Prostate Cancer Trial in Glen Burnie, Omaha, Knoxville (PSMA-Targeted [In-111]-Labeled Trillium Compound, PTI-122)
Recruiting
- Prostate Cancer
- PSMA-Targeted [In-111]-Labeled Trillium Compound
- PTI-122
-
Glen Burnie, Maryland
- +2 more
Mar 21, 2023
Ulcerative Colitis Chronic Moderate, Ulcerative Colitis Chronic Severe Trial in Spain (OST-122, Placebo)
Completed
- Ulcerative Colitis Chronic Moderate
- Ulcerative Colitis Chronic Severe
- OST-122
- Placebo
-
Santiago de Compostela, A Coruña, Spain
- +15 more
Jan 11, 2023
Carcinoma, Hepatocellular Trial in Worldwide (CC-122, Nivolumab)
Completed
- Carcinoma, Hepatocellular
-
Los Angeles, California
- +13 more
Apr 16, 2021
Lymphoma, Large B-Cell, Diffuse, Lymphoma, Non-Hodgkin Trial in France, Italy, Netherlands (Obinutuzumab, CC-122)
Active, not recruiting
- Lymphoma, Large B-Cell, Diffuse
- Lymphoma, Non-Hodgkin
-
Borddeaux Cedex, France
- +9 more
Nov 11, 2022
Outcomes in Critically Ill Patients With COVID-19
Active, not recruiting
- Coronavirus Infection
- No intervention
-
Boston, MassachusettsBrigham and Women's Hospital
Oct 16, 2022
COVID-19 Trial in Taichung (UB-612)
Completed
- COVID-19
- UB-612
-
Taichung, TaiwanChina Medical University Hospital
Aug 25, 2022
COVID-19 Pandemic Trial in Kansas City (Tri-City COVID Attitudes Study)
Recruiting
- COVID-19 Pandemic
- Tri-City COVID Attitudes Study
-
Kansas City, KansasUniversity of Kansas Medical Center
Dec 5, 2022
COVID-19, Pregnant Women Trial in Doha
Recruiting
- COVID-19
- Pregnant Women
-
Doha, QatarWomen's Wellness and Research Center
May 16, 2022
COVID-19 Infection on Respiratory Muscle Strength and Core
Completed
- COVID-19
- +2 more
-
Istanbul, Maltepe, TurkeyBezmialem Vakif University Dragos Hospital
Jul 14, 2022
Exertional Dyspnea and Exercise Intolerance in COVID-19
Active, not recruiting
- Covid19
- Dyspnea
- No Intervention
-
Edmonton, Alberta, CanadaClinical Physiology Laboratory
Dec 5, 2022